Methotrexate Sodium
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Eugia US LLC | unknown | 7 | SUPPLYING |
| Hospira, Inc. | unknown | 6 | SUPPLYING |
| Alembic Pharmaceuticals Limited | unknown | 4 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Methotrexate Sodium Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Oncology, Rheumatology.
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC
The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution. — Recalling firm: Hospira Inc. — Nationwide, including Puerto Rico and Guam. Product was also distributed internationally to Australia, Belgium, Cana…
Pill